tiprankstipranks
Sinco Pharmaceuticals Holdings Ltd. (HK:6833)
:6833
Hong Kong Market
6833
Sinco Pharmaceuticals Holdings Ltd.
RESEARCH TOOLSreports
Want to see HK:6833 full AI Analyst Report?

Sinco Pharmaceuticals Holdings Ltd. (6833) Ratios

0 Followers

Sinco Pharmaceuticals Holdings Ltd. Ratios

HK:6833's free cash flow for Q4 2025 was ¥0.10. For the 2025 fiscal year, HK:6833's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.18 1.18 1.14 1.16 1.29
Quick Ratio
 0.95 0.95 0.87 1.08 1.17
Cash Ratio
 0.33 0.33 0.23 0.36 0.42
Solvency Ratio
 0.05 0.05 0.05 0.05 0.09
Operating Cash Flow Ratio
 0.16 0.15 -0.17 0.29 0.09
Short-Term Operating Cash Flow Coverage
 0.99 0.93 -0.68 1.47 0.42
Net Current Asset Value
¥ 201.88M¥ 201.88M¥ 174.66M¥ 170.66M¥ 196.88M
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.10 0.18 0.13 0.14
Debt-to-Equity Ratio
 0.26 0.26 0.53 0.40 0.32
Debt-to-Capital Ratio
 0.21 0.21 0.35 0.29 0.24
Long-Term Debt-to-Capital Ratio
 0.00 0.00 <0.01 <0.01 <0.01
Financial Leverage Ratio
 2.66 2.66 3.02 3.01 2.36
Debt Service Coverage Ratio
 0.40 0.39 0.21 0.27 0.41
Interest Coverage Ratio
 2.74 2.20 7.57 11.03 6.51
Debt to Market Cap
 0.54 0.57 0.88 0.56 0.38
Interest Debt Per Share
 0.10 0.11 0.17 0.13 0.10
Net Debt to EBITDA
 -1.98 -1.96 0.32 -1.48 -1.25
Profitability Margins
Gross Profit Margin
10.59%10.51%10.63%12.73%13.47%
EBIT Margin
3.59%3.58%4.04%4.32%4.46%
EBITDA Margin
4.66%4.80%4.70%4.96%4.80%
Operating Profit Margin
2.98%3.58%3.37%4.26%3.96%
Pretax Profit Margin
2.32%2.32%3.51%3.93%4.37%
Net Profit Margin
1.68%1.67%1.49%1.67%3.06%
Continuous Operations Profit Margin
1.68%1.67%1.49%1.67%3.06%
Net Income Per EBT
72.15%72.22%42.50%42.40%69.96%
EBT Per EBIT
78.03%64.63%104.19%92.34%110.38%
Return on Assets (ROA)
1.88%1.84%2.10%2.24%4.88%
Return on Equity (ROE)
5.03%4.89%6.34%6.74%11.50%
Return on Capital Employed (ROCE)
8.85%10.46%14.20%16.42%14.19%
Return on Invested Capital (ROIC)
5.06%5.98%3.98%5.08%7.79%
Return on Tangible Assets
2.01%1.97%2.22%2.36%5.17%
Earnings Yield
10.08%10.50%10.81%9.78%14.61%
Efficiency Ratios
Receivables Turnover
 3.50 3.43 4.63 4.70 6.47
Payables Turnover
 2.03 1.99 2.84 2.56 4.82
Inventory Turnover
 7.13 7.00 7.16 20.52 21.94
Fixed Asset Turnover
 5.76 5.65 7.60 7.17 7.19
Asset Turnover
 1.12 1.10 1.41 1.34 1.59
Working Capital Turnover Ratio
 10.40 10.58 14.78 11.87 9.66
Cash Conversion Cycle
 -24.41 -24.76 1.28 -47.23 -2.68
Days of Sales Outstanding
 104.37 106.38 78.82 77.67 56.44
Days of Inventory Outstanding
 51.21 52.16 51.01 17.79 16.63
Days of Payables Outstanding
 179.99 183.30 128.54 142.69 75.76
Operating Cycle
 155.58 158.53 129.83 95.46 73.08
Cash Flow Ratios
Operating Cash Flow Per Share
 0.09 0.08 -0.11 0.17 0.04
Free Cash Flow Per Share
 0.08 0.08 -0.13 0.14 0.01
CapEx Per Share
 <0.01 <0.01 0.02 0.03 0.03
Free Cash Flow to Operating Cash Flow
 0.94 0.94 1.15 0.82 0.30
Dividend Paid and CapEx Coverage Ratio
 13.08 12.70 -5.49 4.28 1.42
Capital Expenditure Coverage Ratio
 17.92 17.34 -6.62 5.48 1.42
Operating Cash Flow Coverage Ratio
 0.99 0.92 -0.66 1.41 0.39
Operating Cash Flow to Sales Ratio
 0.09 0.08 -0.08 0.14 0.03
Free Cash Flow Yield
50.00%49.42%-68.91%66.80%4.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.87 9.52 9.25 10.22 6.84
Price-to-Sales (P/S) Ratio
 0.16 0.16 0.14 0.17 0.21
Price-to-Book (P/B) Ratio
 0.49 0.47 0.59 0.69 0.79
Price-to-Free Cash Flow (P/FCF) Ratio
 1.99 2.02 -1.45 1.50 21.23
Price-to-Operating Cash Flow Ratio
 1.89 1.91 -1.67 1.22 6.33
Price-to-Earnings Growth (PEG) Ratio
 -0.56 -0.49 -19.24 -0.26 -0.12
Price-to-Fair Value
 0.49 0.47 0.59 0.69 0.79
Enterprise Value Multiple
 1.55 1.36 3.25 1.96 3.11
Enterprise Value
 150.79M 132.13M 431.18M 246.36M 338.65M
EV to EBITDA
 1.57 1.36 3.25 1.96 3.11
EV to Sales
 0.07 0.07 0.15 0.10 0.15
EV to Free Cash Flow
 0.88 0.83 -1.61 0.85 15.12
EV to Operating Cash Flow
 0.83 0.78 -1.85 0.70 4.51
Tangible Book Value Per Share
 0.28 0.28 0.26 0.26 0.26
Shareholders’ Equity Per Share
 0.34 0.34 0.32 0.31 0.30
Tax and Other Ratios
Effective Tax Rate
 0.28 0.28 0.57 0.58 0.30
Revenue Per Share
 1.01 1.00 1.34 1.25 1.12
Net Income Per Share
 0.02 0.02 0.02 0.02 0.03
Tax Burden
 0.72 0.72 0.43 0.42 0.70
Interest Burden
 0.65 0.65 0.87 0.91 0.98
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.07 0.07 0.07 0.04 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 5.22 4.99 -2.35 3.54 1.08
Currency in CNY